Foresite Capital Management IV’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $26.6M | Hold |
|
|||||
|
2023
Q2 | $19.6M | Hold |
|
|||||
|
2023
Q1 | $15.6M | Hold |
|
|||||
|
2022
Q4 | $11.2M | Hold |
|
|||||
|
2022
Q3 | $6.25M | Hold |
|
|||||
|
2022
Q2 | $5.27M | Hold |
|
|||||
|
2022
Q1 | $5.56M | Hold |
|
|||||
|
2021
Q4 | $6.04M | Hold |
|
|||||
|
2021
Q3 | $6.52M | Hold |
|
|||||
|
2021
Q2 | $7.79M | Hold |
|
|||||
|
2021
Q1 | $8.11M | Hold |
|
|||||
|
2020
Q4 | $10.3M | Hold |
|
|||||
|
2020
Q3 | $12.9M | Sell |
|
|||||
|
2020
Q2 | $9.93M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $4.54M | Buy |
|
|||||
|
2019
Q3 | $10.5M | Sell |
|
|||||
|
2019
Q2 | $18.4M | Sell |
|
|||||
|
2019
Q1 | $34.9M | Hold |
|
|||||
|
2018
Q4 | $20.7M | Buy |
|
|||||
|
2018
Q3 | $22.4M | Hold |
|
|||||
|
2018
Q2 | $27.2M | Sell |
|
|||||
|
2018
Q1 | $27.4M | Sell |
|
|||||
|
2017
Q4 | $20.7M | Buy |
|